Document Detail

PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in -vitro.
MedLine Citation:
PMID:  21930169     Owner:  NLM     Status:  Publisher    
RNA interference is increasingly being utilized for the specific targeting and down-regulation of disease-causing genes, including targeting viral infections such as HIV. T lymphocytes, the primary target for HIV, are very difficult to treat with gene therapy applications such as RNA interference because of issues with drug delivery. To circumvent these problems, we investigated poly(ethylene imine) (PEI) as a method of improving transfection efficiency of siRNA to T lymphocytes. Additionally, polyethylene glycol (PEG) moieties were engrafted to the PEI polymers with the goals of improving stability and reducing cytotoxicity. Initial studies on PEG-PEI/siRNA polyplex formation, size and their interaction with cell membranes demonstrated their feasibility as drug delivery agents. Assays with lymphocytes revealed low cytotoxicity profiles of the polyplexes at pharmacologically relevant concentrations with PEGylated copolymers obtaining the best results. Successful transfection of a T cell line or primary T cells with siRNA was observed via flow cytometry and confocal microscopy. Finally, the biological effect of copolymer-delivered siRNA was measured. Of particular significance, siRNA targeted to the HIV gene nef and delivered by one of the PEG-PEI copolymers in repetitive treatments every 2-3days was observed to inhibit HIV replication to the same extent as azidothymidine over the course of 15days.
Nick D Weber; Olivia M Merkel; Thomas Kissel; María Ángeles Muñoz-Fernández
Related Documents :
18278869 - Lignans from kadsura angustifolia.
21572819 - Acceptability of routine offer of hiv testing (opt-out approach) among pregnant women i...
22010809 - Developing clinical practice guidelines in hiv rehabilitation: process recommendations ...
17233599 - Combinatorial selection and delivery of thioaptamers.
21844739 - Clinician and patient recognition of anogenital herpes disease in hiv positive men who ...
21998679 - Tracking the evolution of hiv/aids in china from 1989-2009 to inform future prevention ...
21962029 - Diagnosis of latent tuberculosis infection among hiv discordant partners using interfer...
8111489 - Acquired immunodeficiency syndrome--a review and update. history, characteristics of hu...
23223189 - Pathogenesis of hepatitis c during pregnancy and childhood.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-10
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  -     ISSN:  1873-4995     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Laboratorio Inmunobiología Molecular, Hospital General Universitario Gregorio Marañón, C/Doctor Esquerdo 46, 28007 Madrid, Spain; Centro de Investigacíon Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis.
Next Document:  Antimicrobial properties of arginine- and lysine-rich histones and involvement of bacterial outer me...